Mistral Inc. and Uvision Receive an Additional Order Under U.S. Army Lethal Unmanned Systems Program
More than
Valued at more than
HERO 120 systems are being domestically manufactured in support of the U.S. Army Lethal Unmanned Systems program.
This additional order represents an important milestone for Mistral Inc. and Uvision as they continue supporting the U.S. Army's LUS program. The additional systems and equipment will help soldiers train, build proficiency, and prepare to employ a precision strike capability designed for the demands of the modern battlefield.
Under the LUS program, Mistral Inc. and UVision work together to deliver the HERO 120 to the U.S. Army. Uvision is the design authority for HERO 120 and is a major partner in the development, manufacturing, and delivery of the system. Mistral Inc. and Uvision remain focused on providing the DOW with proven capability, responsive support, and reliable delivery as the program continues to advance.
"This is an important step forward for Mistral Inc., UVision, and the U.S. Army's LUS program," said
The HERO 120 loitering munition system supports precision strike capability for modern tactical formations.
"Uvision is proud to support the U.S. Army's LUS program," said
About Mistral Inc.
Mistral Inc., an Ondas company, is a
About Uvision
Uvision Inc. is the design authority for the HERO family of loitering munition systems, including the HERO 120. The company brings deep expertise in the development, manufacturing, delivery, training, and sustainment of advanced loitering munition capabilities for modern military forces. In partnership with Mistral Inc., Uvision plays a central role in delivering the HERO 120 capability to meet U.S. Army operational requirements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mistral-inc-and-uvision-receive-an-additional-order-under-us-army-lethal-unmanned-systems-program-302843869.html
SOURCE Mistral Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs
- Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion
- Harbour BioMed Successfully Included in the Stock Connect, Reinforcing Capital Market Recognition
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share